- Home
- TNYA vs ICCM Comparison
TNYA vs ICCM Comparison
Compare TNYA & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNYA
- ICCM
- Stock Information
- Founded
- TNYA 2016
- ICCM 2006
- Country
- TNYA United States
- ICCM Israel
- Employees
- TNYA N/A
- ICCM N/A
- Industry
- TNYA Medicinal Chemicals and Botanical Products
- ICCM
- Sector
- TNYA Health Care
- ICCM
- Exchange
- TNYA Nasdaq
- ICCM Nasdaq
- Market Cap
- TNYA 73.8M
- ICCM 55.8M
- IPO Year
- TNYA 2021
- ICCM N/A
- Fundamental
- Price
- TNYA $0.60
- ICCM $1.01
- Analyst Decision
- TNYA Strong Buy
- ICCM Strong Buy
- Analyst Count
- TNYA 5
- ICCM 1
- Target Price
- TNYA $8.60
- ICCM $2.50
- AVG Volume (30 Days)
- TNYA 3.0M
- ICCM 287.1K
- Earning Date
- TNYA 08-07-2025
- ICCM 08-19-2025
- Dividend Yield
- TNYA N/A
- ICCM N/A
- EPS Growth
- TNYA N/A
- ICCM N/A
- EPS
- TNYA N/A
- ICCM N/A
- Revenue
- TNYA N/A
- ICCM $3,273,000.00
- Revenue This Year
- TNYA N/A
- ICCM $83.41
- Revenue Next Year
- TNYA N/A
- ICCM $185.02
- P/E Ratio
- TNYA N/A
- ICCM N/A
- Revenue Growth
- TNYA N/A
- ICCM 0.34
- 52 Week Low
- TNYA $0.36
- ICCM $0.48
- 52 Week High
- TNYA $4.06
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- TNYA 52.95
- ICCM 45.31
- Support Level
- TNYA $0.54
- ICCM $0.81
- Resistance Level
- TNYA $0.70
- ICCM $1.03
- Average True Range (ATR)
- TNYA 0.06
- ICCM 0.06
- MACD
- TNYA -0.00
- ICCM 0.01
- Stochastic Oscillator
- TNYA 40.74
- ICCM 71.83
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.